Decompressive craniectomy combined with mild hypothermia in patients with large hemispheric infarction: A randomized controlled trial
Preprint
- 6 November 2020
- preprint
- Published by Springer Nature in Research Square
Abstract
Background: The effect of hypothermia on large hemispheric infarction (LHI) remains controversial. Our study aimed to explore the therapeutic outcomes of decompressive craniectomy (DC) combined with hypothermia on LHI.Methods: Patients were randomly divided into three groups: the DC group, the DC plus head surface cooling (DCSC) group and the DC plus endovascular hypothermia (DCEH) group. The DC group was maintained normothermia. The DCSC group received 24-hour ice cap on the head for 7 days. While the DCEH group were given endovascular hypothermia (34°C ). Mortality and modified Rankin Scale (mRS) score at 6 months were evaluated.Results: Thirty-four patients were included in the study. Mortality of the DC, DCSC and DCEH groups at discharge were 22.2% (2/9), 0% (0/14) and 9.1% (1/11), respectively. However, it increased to 44.4% (4/9), 21.4% (3/14) and 45.5% (5/11) at 6 months, respectively (P=0.367) . Pneumonia (8 cases) was the leading cause of death after discharge. Twelve cases (35.3%) achieved good neurological outcome (mRS 0-3) at 6 months. The proportions of good neurological outcome in the DC, DCSC and DCEH groups were 22.2% (2/9 cases), 42.9% (6/14 cases) and 36.4% (4/11), respectively. The DCSC group seemed to have higher proportion of good outcomes, but there was no significant difference between groups (p=0.598). Among survivors, endovascular hypothermia had a higher proportion of good outcome (DC group, 2/5 cases, 40.0%; DCSC group, 6/11 cases, 54.5%; DCEH group, 4/6 cases, 66.7%; p=0.696). The incidence of complications in the DCEH group was higher than those of the DC and DCSC groups (18.9%, 12.0%, and 12.1%, respectively; P=0.025).Conclusions: There is still no evidence to confirm that hypothermia further reduces long-term mortality and improves neurological outcomes in LHI patients with DC. However, there is a trend to benefit survivors from hypothermia. A local cooling method may be a better option for DC patients, which has little impact on systematic complications.Clinical Trial Registration-Decompressive Hemicraniectomy Combined Hypothermia in Malignant Middle Cerebral Artery Infarct, ChiCTR-TRC-12002698. Registered 11 Oct 2012- Retrospectively registered, URL: http://www.chictr.org.cn.Keywords
All Related Versions
This publication has 20 references indexed in Scilit:
- Outcomes of therapeutic hypothermia in patients treated with decompressive craniectomy for malignant Middle cerebral artery infarction: A systematic review and meta-analysisClinical Neurology and Neurosurgery, 2020
- Selective Brain Hypothermia Augmenting Neuroprotective Effects of Decompressive Craniectomy for Permanent Middle Cerebral Artery Infarction in a Rat ModelWorld Neurosurgery, 2019
- Rehabilitation of Swallowing and Cough Functions Following Stroke: An Expiratory Muscle Strength Training TrialArchives of Physical Medicine and Rehabilitation, 2016
- Glibenclamide enhances the effects of delayed hypothermia after experimental stroke in ratsBrain Research, 2016
- Hypertonic saline versus other intracranial pressure-lowering agents for people with acute traumatic brain injuryCochrane Database of Systematic Reviews, 2014
- Decompressive Hemicraniectomy in Malignant Middle Cerebral Artery Infarct: A Randomized Controlled Trial Enrolling Patients up to 80 Years OldNeurocritical Care, 2012
- Glibenclamide—10-h Treatment Window in a Clinically Relevant Model of StrokeTranslational Stroke Research, 2012
- Adjunctive Functional Pharyngeal Electrical Stimulation Reverses Swallowing Disability After Brain LesionsGastroenterology, 2010
- Surgical decompression for space-occupying cerebral infarction (the Hemicraniectomy After Middle Cerebral Artery infarction with Life-threatening Edema Trial [HAMLET]): a multicentre, open, randomised trialThe Lancet Neurology, 2009
- Hypothermia enhances bcl-2 expression and protects against oxidative stress-induced cell death in chinese hamster ovary cellsFree Radical Biology and Medicine, 2001